Remove 2022 Remove Life Science Remove Medicare Remove Pharmaceuticals
article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

health citizens’ memories will last into 2022 with respect to cross-party desire for the U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies]. Hospitals’ fall from 70% to 63% between 2018 and 2019. Consumer health’s fall from 63% in 2019 to 51% in 2020.

BioTech 310
article thumbnail

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Health Populi

is heating up, with President Biden mentioning the scenario of Medicare negotiating drug prices with pharmaceutical manufacturers in his latest speech measuring progress at 100 days in the White House. As such, the debate on prescription drug pricing in the U.S.